I. UNDERSTANDING THE CANCER 1. Introduction to cancer 2. Current practices in cancer chemotherapy 3. Emerging trend in anticancer drug delivery 4. Cancer therapy depending on tumor stroma 5. Cancer therapy depending on cancer cell respiration: pH and hypoxia 6. Cancer therapy depending on tumor vasculature and EPR effects.

7. Cancer therapy based on extracellular matrix 8. Heterogenicity of cancer and drug resistance II. STRATEGIES AND TECHNOLOGIES FOR CANCER THERAPY 9. Materials and strategies for advanced anticancer drug delivery 10. Drug Conjugates for anticancer drug delivery 11. Microparticles for anticancer drug delivery 12. Self-assembled supramolecular systems for anticancer drug delivery 13.

Advances in metal-organic frameworks for anticancer drug delivery 14. Nanotechnology for anticancer drug delivery: possibilities and limitations 15. Tumor microenvironment targeted drug delivery systems 16. Advances in dendrimers for anticancer drug delivery 17. Advances in metallic nanoparticles for anticancer drug delivery 18. Advances in polymeric nanoparticles for anticancer drug delivery 19. Advances in lipid-based nanoparticles for anticancer drug delivery 20. Advances in SNEDDS for anticancer drug delivery 21.

Advances in nanocrystals for anticancer drug delivery 22. Theranostic nanoparticles for advanced cancer therapy 23. Advances in hydrogel for anticancer drug delivery 24. Nanofibrous scaffolds for cancer management 25. Genetic nanomaterials for anticancer drug delivery 26. Organic nanocarriers for anticancer drug delivery 27. Microneedles for anticancer drug delivery 28. Implants for anticancer drug delivery 29.

Phytoconstituents based anticancer drug delivery systems III. CLINICAL STATUS, CHALLENGES AND FUTURE PROSPECTIVES 30. Clinical status of anticancer drug delivery systems 31. Challenges and future prospectives in anticancer drug delivery 32. Regulatory considerations for anticancer drug delivery systems.